Cancer/Gene Therapy

Multi-Site Trial for Inoperable Brain Tumors Initiated

Published in Gene Therapy Weekly, March 20th, 1995

Genetic Therapy Inc. (GTI), Gaithersburg, Maryland, announced that it has initiated a multi-center Phase I/II clinical trial using gene therapy to treat inoperable malignant brain tumors as part of its program to develop gene therapy products for brain cancer.

This trial is being conducted in parallel with another GTI-sponsored Phase I/II clinical trial for operable malignant brain tumors currently ongoing at three trial sites.

In this study, an initial 15 patients will be enrolled. The protocol involves a direct injection into the tumor of cells that produce genetically altered vectors, which transfer into tumor cells the gene for the enzyme...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1995-03-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry